[Rinsho Byori 50 : 502`505, 2002]

Increase of Soluble FcRIIIa Derived from Macrophages in Plasma
from Patients with Atherosclerosis


Midori MASUDA*1 and Hakuo TAKAHASHI, MD*2<

Macrophages play a major role in the development of vascular lesions in atherogenesis. The cells express FcRIIIa(CD16) identical to that in NK cells, but with a cell type-specific glycosylation. In contrast, neutrophils express FcRIIIb in two allotypes, NA1- and NA2- Fc RIIIb. These FcRIIIs are released from the cell surface on activation, and these soluble forms(sFcRIII) are present in plasma. In the present study, we measured sFcRIIIaM in plasma with Immuno-PCR with newly-developed anti-FcRIII mAb, MKGR14(mIgM), which recognizes FcRIIIaM specifically. In healthy donors, the level of sFcRIIIaM increased with age. In contrast, the sFcRIIIa level correlated with the number of NK cells in peripheral blood, and the level of total sFcRIII(sFcRIIIa plus sFcRIIIb) correlated with the number of neutrophils. There was no correlation among the levels of three sFcRIIIs was observed in healthy donors. The levels of these sFcRIII were significantly increased in patients with coronary artery disease(CAD) compared with age-matched healthy donors. The sFcRIIIaM level was related to the number of significant coronary artery stenoses, and correlated with the sFcRIIIa level, total cholesterol, HDL-cholesterol(negatively), LDL to HDL ratio, triglycerides and body mass index. These findings may show that the macrophages are activated during the incipient stage of atherosclerosis, and that sFcRIIIaM may serve as predictive marker for atherosclerosis.


*1Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Moriguchi 570-8506

yKey Wordszatherosclerosis, macrophages, Fcreceptor type III